Key F Inancial Inc Neurocrine Biosciences Inc Transaction History
Key F Inancial Inc
- $433 Million
- Q4 2024
A detailed history of Key F Inancial Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Key F Inancial Inc holds 34 shares of NBIX stock, worth $5,161. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 34
-0.0%
Holding current value
$5,161
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
638Shares Held
93.8MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.15 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.52 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$782 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$391 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$283 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...